Xueru Chu
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17.
Journal: Frontiers in pharmacology
Published: February 05, 2026
Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model.
Journal: Lipids in health and disease
Published: January 09, 2025
Predictive effect and clinical diagnosis significance of exosome-related genes for nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Journal: Scientific reports
Published: September 12, 2024
Salidroside may target PPARα to exert preventive and therapeutic activities on NASH.
Journal: Frontiers in pharmacology
Published: May 15, 2024
TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD.
Journal: Clinical and molecular hepatology
Published: April 16, 2024
miR-468-3p suppresses osteogenic differentiation of BMSCs by targeting Runx2 and inhibits bone formation.
Journal: Journal of orthopaedic surgery and research
Published: April 10, 2024
Chaetomorpha linum polysaccharides alleviate NAFLD in mice by enhancing the PPARα/CPT-1/MCAD signaling.
Journal: Lipids in health and disease
Published: September 28, 2022
MiR-146a-5p, targeting ErbB4, promotes 3T3-L1 preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway.
Journal: Lipids in health and disease
Published: December 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026